Hepatitis B Therapeutic Vaccine Appears Safe and Stimulates Immune Response
SUMMARY: In late December, Dynavax Technologies reported findings from a small early clinical trial showing that its investigational hepatitis B virus therapeutic vaccine DV-601 -- intended to help control the virus in people already infected, rather than prevent infection -- was well tolerated and produced immunological and virological responses ...
Join the discussion below, or Read more at HIV and Hepatitis.
Tel Aviv, Israel
#1 Feb 17, 2011
I didnt know much about DVAX but i bought a nice analysis report that covers them well.
It was mentioned on the report about their HB Vaccine. You can find the report @ www.BiotechExplorers.com
#2 Feb 17, 2011
I also got a report from www.biotechexplorers.com them about DVAX. It really made my life a lot easier.
Add your comments below
|Dynavax Technologies Corporation and GlaxoSmith... (Oct '11)||Oct '11||A CHRISTIAN||1|
|Dynavax Appoints Chief Medical Officer (Jun '09)||Jun '09||andrew j langham||1|
|Hay Fever Vaccine Holds Promise, Say Scientists (Oct '06)||Oct '06||John Lipshield moboy||1|
Find what you want!
Search Dynavax Technologies Forum Now
Copyright © 2015 Topix LLC